Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
In patients with Duchenne Muscular Dystrophy who have an exon 51 mutation, do you treat with both prednisone and Eteplirsen?
What are common side effects to look out for with Eteplirsen?
Related Questions
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
When do you consider CSF testing for patients with suspected ALS?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
What is your approach to managing seronegative myasthenia gravis in patients who have not responded to immunotherapy?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
How frequently do you re-evaluate AChR and MuSK antibodies in patients with clinical and electrodiagnostic evidence of seronegative myasthenia gravis?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
How do you counsel patients with genetically confirmed Fabry disease regarding switching from agalsidase beta (Fabrazyme) to Migalastat (Galafold)?
How do you treat fatigue symptoms in myasthenia gravis?
When would you consider testing for LGI1 antibodies in patients with unexplained neuropathic pain?